Related references
Note: Only part of the references are listed.Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
Jeffrey J. Bednarski et al.
BLOOD (2022)
Decrease post-transplant relapse using donor-derived expanded NK-cells
Stefan O. Ciurea et al.
LEUKEMIA (2022)
Chemokine networks modulating natural killer cell trafficking to solid tumors
Xue Yao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Generating natural killer cells for adoptive transfer: expanding horizons
Soumyadipta Kundu et al.
CYTOTHERAPY (2021)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
Adeline Raynaud et al.
ONCOIMMUNOLOGY (2021)
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Mubin Tarannum et al.
STEM CELL RESEARCH & THERAPY (2021)
Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?
Alaa Kassim Ali et al.
CANCER JOURNAL (2021)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments
Olivier Demaria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano et al.
CANCERS (2021)
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Faroogh Marofi et al.
FRONTIERS IN ONCOLOGY (2021)
iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
Peter Karagiannis et al.
MOLECULES AND CELLS (2021)
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
C. Quintarelli et al.
LEUKEMIA (2020)
Overexpressed CXCR4 and CCR7 on the surface of NK92 cell have improved migration and anti-tumor activity in human colon tumor model
Lili Yang et al.
ANTI-CANCER DRUGS (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
Yu Yang Ng et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Off-the-shelf ipsc derived car-nk immunotherapy for solid tumors
N.R. Boyd et al.
CYTOTHERAPY (2020)
Mechanism of tumor cells escaping from immune surveillance of NK cells
Zhe Ge et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Aviad Ben-Shmuel et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy
Young Ha Ahn et al.
BIOMATERIALS (2020)
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
Huang Zhu et al.
CELL STEM CELL (2020)
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia
Melissa M. Berrien-Elliott et al.
CANCER DISCOVERY (2020)
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
Benjamin H. Goldenson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
Yan Yang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
Daniel A. Vallera et al.
CANCERS (2020)
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yilmaz et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
Simone Mantesso et al.
FRONTIERS IN IMMUNOLOGY (2020)
Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy
Jie Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial
Roman M. Shapiro et al.
BLOOD (2020)
Engineered Memory-like NK Cars Targeting a Neoepitope Derived from Intracellular NPM1c Exhibit Potent Activity and Specificity Against Acute Myeloid Leukemia
Han Dong et al.
BLOOD (2020)
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
Rachel A. Burga et al.
CLINICAL CANCER RESEARCH (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Dean A. Lee
IMMUNOLOGICAL REVIEWS (2019)
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
Kristina Ellwanger et al.
MABS (2019)
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
Marjolein Schluck et al.
FRONTIERS IN IMMUNOLOGY (2019)
Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
SoonHo Kweonl et al.
FRONTIERS IN IMMUNOLOGY (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
Cytokine-Induced Memory-like (ML) NK Cells Persist for > 2 Months Following Adoptive Transfer into Leukemia Patients with a MHC-Compatible Hematopoietic Cell Transplant (HCT)
Jennifer A. Foltz et al.
BLOOD (2019)
BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
Sumithira Vasu et al.
BLOOD (2019)
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
Chao Yang et al.
NATURE COMMUNICATIONS (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
Yuan Hu et al.
ENGINEERING (2019)
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
Annekathrin Heinze et al.
FRONTIERS IN IMMUNOLOGY (2019)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley et al.
BLOOD ADVANCES (2019)
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
Cristiana Lo Nigro et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Metabolic interventions in the immune response to cancer
David O'Sullivan et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Cytokines in Cancer Immunotherapy
Thomas A. Waldmann
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong et al.
CELL METABOLISM (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
Fevzi Firat Yalniz et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Activation of Human Natural Killer Cells by Graphene Oxide-Templated Antibody Nanoclusters
Christian Loftus et al.
NANO LETTERS (2018)
Natural killer cells' immune response requires a minimal nanoscale distribution of activating antigens
Yossi Keydar et al.
NANOSCALE (2018)
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
Folashade Otegbeye et al.
PLOS ONE (2018)
Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution
Shelly M. Williams et al.
TRANSFUSION (2018)
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
Norbert Vey et al.
Oncotarget (2018)
A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Wing Keung Chan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer.
Neil Howard Segal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells
Fatemeh Vahedi et al.
SCIENTIFIC REPORTS (2017)
Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
Jorg U. Schmohl et al.
CANCER RESEARCH AND TREATMENT (2017)
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Markus Granzin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
Anushruti Sarvaria et al.
FRONTIERS IN IMMUNOLOGY (2017)
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Veronika Kremer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells
Wooram Park et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
David L. Hermanson et al.
STEM CELLS (2016)
Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+Colorectal Cancer Cells
J. U. Schmohl et al.
TARGETED ONCOLOGY (2016)
Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors
N. H. Segal et al.
ANNALS OF ONCOLOGY (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF
Francesca Moretta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
Markus Granzin et al.
ONCOIMMUNOLOGY (2016)
Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
Jeremiah L. Oyer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Achim Rothe et al.
BLOOD (2015)
Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
Markus Granzin et al.
CYTOTHERAPY (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Super-resolution Imaging of the Natural Killer Cell Immunological Synapse on a Glass-supported Planar Lipid Bilayer
Peilin Zheng et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
Uwe Reusch et al.
MABS (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies
Salem Chouaib et al.
FRONTIERS IN IMMUNOLOGY (2014)
Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line
Duk Seong Bae et al.
BLOOD RESEARCH (2014)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
Daniel A. Vallera et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
Wenxin Xu et al.
CANCER RESEARCH (2013)
Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
Jonathan Sitrin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2013)
Nanoscale Ligand Spacing Influences Receptor Triggering in T Cells and NK Cells
Derfogail Delcassian et al.
NANO LETTERS (2013)
Bringing natural killer cells to the clinic: ex vivo manipulation
Richard W. Childs et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
Srinivas S. Somanchi et al.
BLOOD (2012)
Cytokine activation induces human memory-like NK cells
Rizwan Romee et al.
BLOOD (2012)
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill et al.
BLOOD (2012)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions
Jacques Deguine et al.
JOURNAL OF IMMUNOLOGY (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions
Ido D. Weiss et al.
CYTOKINE (2011)
Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance
Ariane Groth et al.
JOURNAL OF INNATE IMMUNITY (2011)
CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A
D. N. Eissens et al.
LEUKEMIA (2010)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
Replicative potential of human natural killer cells
Hiroyuki Fujisaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Integrin-Dependent Organization and Bidirectional Vesicular Traffic at Cytotoxic Immune Synapses
Dongfang Liu et al.
IMMUNITY (2009)
Permanent silencing of NKG2A expression for cell-based therapeutics
Constanca Figueiredo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Physical approaches to biomaterial design
Samir Mitragotri et al.
NATURE MATERIALS (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
Loredana Ruggeri et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation
Janet North et al.
JOURNAL OF IMMUNOLOGY (2007)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Intratumoral recombinant human interleukin-12 administration in head and neck squamous (cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor
CML van Herpen et al.
CLINICAL CANCER RESEARCH (2005)
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma
ES Doubrovina et al.
JOURNAL OF IMMUNOLOGY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Share Paper
